Year: 2025
Type: article
Abstract: Facial lipoatrophy in patients with HIV is a well-established adverse effect of highly active antiretroviral therapy (HAART), further augmenting stigma and decreasing treatment adherence. Poly-L-lactic acid (PLLA) is approved by the US Food and Drug Administration for the correction of facial fat loss in this population. Unfortunately, needle obstruction from microparticles is a common obstacle that clinicians may encounter during this procedure. We describe a simple and effective way to mitigate this problem by utilizing a water bath to warm the filler prior to injection.
Source: Cutis
DOI: 10.12788/cutis.1300
Author: Elliott Herron
Institutions: University of Alabama at Birmingham, UAB Medicine
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7124316562
FWCI:
Cites:
Cited by:
Related to: